Introduction
============

The liver is one of the largest and most important organs in the body, and it plays a crucial role in the metabolism of nutrients. Liver dysfunction is usually associated with severe protein malnutrition and patients with severe liver cirrhosis experience a severe catabolic state, in which fatty acids are used as a source of energy \[[@B1]\]. Hence many patients awaiting liver transplantation show various forms of nutritional deficiency, which increases the chance of occuring infection-related diseases after transplantation, increases mortality, and is associated with a reduction in quality of life \[[@B2]\]. Liver transplantation is a pioneering method for treating unresectable liver cancer and, acute or chronic liver failure with a survival period of less than 1 year \[[@B3]\]. In 2013, a total of 1,186 liver transplants were performed in South Korea, and the 1-year survival rate after liver transplantation has been improved on annual basis. The 1-year survival rate at 2013 was 76.9% for cadaveric donor liver transplantation (CDLT) and 88.6% for live donor liver transplantation (LDLT) \[[@B4]\]. It is anticipated that the demand for liver transplantation and the frequency of surgeries will be increased.

The nutritional deficiency rate in chronic liver disease patients is approximately 65-100%, and in the recipients of liver transplants is 30-50% \[[@B5]\]. Among liver transplant patients, severe malnutrition group prior to transplantation are reported to require a larger volume of blood transfusion during surgery than well-nourished group and these patients are also likely to have an extended hospitalization period after transplantation \[[@B6]\]. As a method of evaluating the nutritional status of patients waiting for liver transplants, the Subjective Global Assessment (SGA) has shown high reliability, and has also demonstrated a strong significant association with postoperative anthropometric indices \[[@B7]\]. Severe muscle depletion and malnutrition status before transplantation have been reported to be associated with 1-year postoperative mortality \[[@B8]\]. Thus, there have been various studies emphasizing the importance of improving nutritional conditions before and after liver transplantation surgery. Nevertheless, it is essential to assess the risk of malnutrition before seeking the way to improve patients\' nutritional conditions. Although there are several nutrition assessment tools currently in use in clinics and hospitals of South Korea and overseas, there have been almost no studies of liver transplant patients in Korea.

The present study was a prospective study in which various nutritional screening tools were applied before and after surgery in liver transplant patients to compare diagnosis rate of malnutrition according to these nutritional screening tools and to verify the most useful tools in terms of correlation with mortality.

Materials and Methods
=====================

Patients
--------

Patients who were awaiting a liver transplant at Soonchunhyang University Hospital Bucheon and consented to the aims of the study were included as subjects. A total of 39 patients were initially recruited, but after the exclusion of 6 patients who refused to participate. Patients at the start of the study were 33 patients (23 males, 10 females). The total number of patients at the end of the study were 28 patients because 5 patients were expired in the middle of the study. Several investigations were conducted through individual interviews before transplantation, discharge after transplantation, and during follow-up visits as an outpatient at 3, 6, and 12 months after transplantation. The patients and guardians were educated in methods of diet management. This study was approved by the Institutional Review Board of Soonchunhyang University and all subjects provided written informed consent. [Figure 1](#F1){ref-type="fig"} displays a flow diagram of patient\'s participation.

Clinicopathologic data
----------------------

The subjects\' gender, age, and reason for liver transplantation were analyzed, and the type of liver transplant was classified as either LDLT or CDLT. In order to ascertain liver transplantation urgency, patients were categorized as A, B, or C, according to the Child-Turcotte-Pugh (CTP) staging method \[[@B9]\], with the majority of patients waiting for a liver transplant belonging to class B or C. In addition, the Model for End-Stage Liver Disease (MELD) score, currently used by the United Network for Organ Sharing (UNOS) was calculated, with liver transplantation recommended for patients with scores of 16 points or more \[[@B10]\]. This score make clinicians distinguish patients who are eligible for liver transplantation and is thought to minimize patient drop-out due to death while waiting for a transplant, while maximizing survival after transplantation. The overall length of hospital stay and intensive care unit (ICU) stay was analyzed, and clinical data was investigated using medical records, based on the assessment of a surgeon.

Biochemical analysis
--------------------

A total of 23 items were evaluated through blood tests to investigate trends at different periods before or after transplantation, and these included hemoglobin (Hgb), hematocrit (Hct), white blood cell (WBC) count, lymphocytes, C-reactive protein (CRP), serum albumin, liver function tests, cholesterol, blood glucose, blood urea nitrogen (BUN), creatinine (Cr), magnesium (Mg), sodium (Na), potassium (K), and chloride (Cl).

Nutrient intake survey
----------------------

In order to evaluate nutrient intake, 3-day food records were conducted and analyzed using the computer-aided nutritional analysis program (CAN-Pro 3.0; Korean Nutrition Society, Seoul, Korea).

Nutritional status assessment
-----------------------------

Three different screening tools for malnutrition were used in this study. The Nutritional Risk Screening (NRS) 2002, conceived in Europe, identifies a nutritional risk group with a score of 3 points or greater in a scored assessment. It is unique for including disease severity as a component of the nutritional screening index \[[@B11]\]. The Malnutrition Universal Screening Tool (MUST) provides scores for body mass index (BMI), percentage body weight loss, and acute or chronic disease. It is divided into 3 stages, with patients with scores of 2 points or higher classified as the high-risk group \[[@B12]\], and relatively quick and easy screening tool. The SGA is a subjective nutritional assessment method \[[@B13]\] that has been used in numerous studies. This tool also categorizes patients into one of three stages by considering patients\' body weight changes and metabolic demands.

Statistical analysis
--------------------

Statistical analyses were performed using R 3.1.3 version freely available on the web (<http://cran.r-project.org/>) and SPSS (version 18.0; SPSS, Inc, Chicago, IL, USA). All data were reported as mean ± standard deviation or as number and percentage. In order to identify the diagnostic power of nutritional tools before transplantation in predicting the mortality of liver transplant patients at 12 months postoperation, the sensitivity, specificity, negative predictive values, and positive predictive values were calculated for each nutritional index, and 95% confidence intervals were presented.

Results
=======

Clinicopathologic characteristics
---------------------------------

An average age of the subjects were 47.2 years. There were 23 males (69.7%) and 10 females (30.3%). The major diagnoses were hepatocellular cancer (18.2%), liver cirrhosis (54.5%), alcoholic liver cirrhosis (18.2%), hepatitis (6.1%), and Caroli (3.0%). In type of transplant, 63.6% were CDLT and 36.4% were LDLT. According to the CTP classification, 84.8% of patients belonged to class B or C, while the average MELD score of 20.2 showed that these subjects were suitable candidates for liver transplantation. The average ICU stay was 4.8 days, and the average hospital stay was 18.3 days ([Table 1](#T1){ref-type="table"}).

Change of biochemical data
--------------------------

The results of blood test at pre-transplantation in patients with hepatic failure were very abnormal and unstable. Compared to the normal range, liver function and infection-related values were high before transplantation, while anemia-related values and albumin were low. Biochemical indices which have values in normal range before transplantation were WBC count, lymphocytes, amylase, lipase, cholesterol, Na, K, and Cl. Upon discharge after transplantation, total bilirubin, LDH, BUN, and Mg values were normal. By 3 months postoperation, albumin, ammonia, and Cr values were within the normal range; at 6 months postoperation, Hct, CRP, GOT, and GPT were normal; and at 12 months postoperation, Hgb, direct bilirubin, ALP, and glucose values were normal ([Table 2](#T2){ref-type="table"}).

Change of nutrient intake
-------------------------

Analysis of nutrients intake are displayed in [Table 3](#T3){ref-type="table"}. By considering age and gender distribution of study participants patients\' nutrient intake were assessed relative to the recommended nutritional allowances \[[@B14]\] for a 40-49-year-old male. Upon discharge, intake of protein, iron, and vitamin B1 had exceeded the dietary reference; at 3 months postoperation, intake of niacin and vitamin E had returned to the level of intake at preoperation; and at 6 months, intake of zinc, vitamin A, and vitamin B2 had increased to the level of dietary reference.However, energy, as well as fiber, calcium, potassium, vitamin C, and folate remained below the reference intake beyond the end of the investigation ([Table 3](#T3){ref-type="table"}).

Prevalence of malnutrition according to the nutritional screening tools
-----------------------------------------------------------------------

[Table 4](#T4){ref-type="table"} displays the results of the malnutrition assessments using nutritional screening tools. The rates of malnutrition before transplantation were very high, reported at 81.8% for the NRS 2002, 87.9% for the MUST, and 84.8% for the SGA. Upon discharge after transplantation, the rates of malnutrition were still high, at 60.6%, 75.8%, and 66.6%, respectively, while these rates decreased to 43.7%, 53.1% and 46.9% at 3 month postoperation. By 6 months postoperation, malnutrition rates decreased to 24.4%, 29.0%, and 25.8% and, at 12 months postoperation, these rates further decreased to 6.1%, 10.7%, and 10.7%, respectively ([Table 4](#T4){ref-type="table"}).

Validity of the nutritional screening tools
-------------------------------------------

In order to test the ability of the screening tools to predict death in patients at risk of malnutrition, sensitivity, specificity, and prediction accuracy of the screening tools were assessed. Sensitivity, which is the proportion of correctly predicted deaths in a group of patients with malnutrition, was 87.1% for the NRS 2002, 82.0% for the MUST, and 92.0% for the SGA, while prediction accuracy was 83.3%, 78.8%, and 91.9%, respectively. The specificity was 74.4%, 61.4% and 79.5%, respectively ([Table 5](#T5){ref-type="table"}).

Discussion
==========

In South Korea, 80% of the patients requiring liver transplants are the patients of liver cirrhosis. The majority are male, and recent changes in perception toward liver transplantation have led a gradual increase in LDLT \[[@B4]\]. The clinical conditions of the participants in the current study showed similar patterns with overall domestic trends. The level of most biochemical indices in blood test were improved to the normal level after transplantation, while a recovery of liver function will take a long time. Nevertheless, close observation and active treatment are required to ensure early recovery of anemia and to maintain normal blood glucose after liver transplantation.

Nutritional assessment and care before and after liver transplantation are very important aspects of treatment. Before transplantation, the majority of patients accompany various complications, including cachexia, ascites, and esophageal varices, and these complication should be considered for patients\' menu plan \[[@B15]\]. After transplantation, adequate nutrients intake is important for the rapid recovery and regrowth of hepatocytes, and additional nutrition care is recommended for preventing obesity and adverse effects of transplantation \[[@B16]\]. Although a large number of patients showed an increase in nutritional intake due to increased appetite and consumption amount, long-term intake of energy, fiber, calcium, potassium, vitamin C, and folate were insufficient to recover their health status implicating that dietary guidance is required for balanced nutrition in their diet. Insufficient nutrient intake after transplantation is known to cause a negative energy balance, and nutritional interventions with nutritionally well-balanced diet before and after transplantation help to improve nutritional status \[[@B17][@B18]\].

Several studies have assessed the nutritional status of patients before and after liver transplantation. Because there is still no gold standard for nutritional assessment in patients with terminal hepatic failure, a large number of studies still use anthropometric values, or serum markers such as serum albumin, prealbumin, and transferrin \[[@B9][@B19]\]. Ha and Choi-Kwon \[[@B20]\] reported that an average malnutrition rate of patients were 51.5% immediately after liver transplantation, which is slightly different from the results of the present study. While nutritional status improves with an increased survival period after surgery, multifaceted studies are required to minimize the rate of malnutrition. Previously comparative studies of malnutrition rates using different assessment tools were conducted for patients with gastric cancer \[[@B21]\] or elderly \[[@B22]\]. In the present study relatively good results were demonstrated with all three nutritional screening tools in terms of sensitivity and accuracy. Of these three tools, the SGA showed the highest predictive power. This is similar to the results of Naveau et al. \[[@B23]\] on patients with chronic liver disease, in which the SGA showed a sensitivity of 96.0%. Our study has some limitations. The number of subjects were too small and the 95% confidence intervals were relatively broad. So, it is difficult to generalize the results. But, this study is valuable because studies on nutritional status for liver transplant patients in South Korea are very rare, and the authors were able to analyze trends in nutritional intake during the survival period after transplantation and to conduct a professional nutritional assessment.

Conclusion
==========

The malnutrition rate of patients in waiting liver transplants is very high. While survival period of post-transplantation is increased the patients still suffer from malnutrition after transplantation. Moreover, the patients\' nutritional status remains inadequate for long time after transplantation. Among the nutritional assessment tools we examined, the SGA had the highest sensitivity and accuracy. Proper nutritional assessment and intervention are difficult for patients with terminal hepatic failure, but the nutrition care is still important and helpful in the treatment of patients who underwent liver transplantation. Hence, a team approach with physicians and dietitians is required to ensure that nutritional support is not delayed, and the accurate nutritional screening tools are used. In the future, long-term studies with larger numbers of participants will be needed to elucidate these issues.
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![Flow diagram of patient\'s participation. LDLT: living donor liver transplantation, CDLT: cadaveric donor liver transplantation.](cnr-4-242-g001){#F1}

###### Clinicopathologic characteristics of patients

![](cnr-4-242-i001)

  -------------------------------------------------------------
                                              Total\
                                              (n = 33)
  ------------------------------------------- -----------------
  Age, years                                  47.2 ± 10.3^\*^

  Gender, n (%)                               

   Male                                       23 (69.7)^†^

   Female                                     10 (30.3)

  Diagnosis, n (%)                            

   HCC                                        6 (18.2)

   LC                                         18 (54.5)

   ALC                                        6 (18.2)

   Hepatitis                                  2 (6.1)

   Caroli                                     1 (3.0)

  Type of transplant, n (%)                   

   LDLT                                       12 (36.4)

   CDLT                                       21 (63.6)

  Child-Pugh stage, n (%)                     

   A                                          5 (15.2)

   B                                          4 (12.1)

   C                                          24 (72.7)

  MELD score                                  20.2 ± 10.9

  Length of ICU stay, days                    4.8 ± 4.5

  Duration of hospitalization (Total), days   18.3 ± 15.8
  -------------------------------------------------------------

HCC: hepatocellular carcinoma, LC: liver cirrhosis, ALC: alcholic liver cirrhosis, HF: hepatic failure, Caroli: caroli syndrome, LDLT: living donor liver transplantation, CDLT: cadaveric donor liver transplantation, MELD: The model for end-stage liver disease score, ICU: intensive care unit.

^\*^Data expressed as mean ± standard deviation; ^†^Data expressed as number (%).

###### Change of biochemical data before and after transplantation

![](cnr-4-242-i002)

  ---------------------------------------------------------------------------------------------------------------------------------------------------
                       Normal range   Preoperative\    Discharge\      Postoperative 3 months\   Postoperative 6 months\   Postoperative 12 months\
                                      (n = 33)         (n = 33)        (n = 32)                  (n = 31)                  (n = 28)
  -------------------- -------------- ---------------- --------------- ------------------------- ------------------------- --------------------------
  Hgb, g/dL            13-17          10.2 ± 2.0^\*^   9.1 ± 1.2       11.1 ± 2.0                12.3 ± 2.2                13.4 ± 1.6

  Hct, %               36-52          29.0 ± 5.6       27.5 ± 3.4      33.1 ± 9.5                48.7 ± 72.9               39.1 ± 6.6

  WBC, ×10^3^/µL       4-10           5.9 ± 4.4        6.3 ± 7.9       4.1 ± 2.4                 8.3 ± 6.2                 5.5 ± 5.7

  Lym, %               15-44          16.6 ± 9.1       13.0 ± 8.2      26.2 ± 13.1               29.6 ± 12.3               29.9 ± 11.8

  CRP, mg/dL           0-0.5          2.4 ± 3.6        1.7 ± 3.3       1.2 ± 1.3                 0.5 ± 0.5                 0.6 ± 0.1

  Alb, g/dL            3.3-52         3.1 ± 0.5        3.2 ± 0.5       3.9 ± 0.5                 4.1 ± 0.5                 4.2 ± 0.3

  GOT, IU/L            5-40           195.3 ± 503.5    68.4 ± 219.7    42.1 ± 58.9               34.8 ± 19.7               35.8 ± 17.5

  GPT, IU/L            0-40           280.4 ± 919.1    98.1 ± 201.3    40.1 ± 64.7               35.2 ± 28.2               41.9 ± 14.8

  T.B, mg/dL           0.2-1.2        11.9 ± 12.5      1.1 ± 0.6       1.2 ± 411.9               1.2 ± 2.0                 1.2 ± 1.0

  D.B, mg/dL           0-0.4          6.3 ± 8.5        0.7 ± 0.5       1.0 ± 1.01                0.7 ± 1.7                 0.4 ± 0.8

  ALP, IU/L            44-119         96.3 ± 43.1      129.5 ± 94.1    144.5 ± 108.4             125.4 ± 103.7             116.8 ± 96.4

  LDH, IU/L            219-480        800.1 ± 358.9    410.1 ± 141.2   438.6 ± 131.9             414.0 ± 55.2              230.0 ± 124.1

  Amylase, IU/L        28-100         60.3 ± 29.7      73.7 ± 40.0     38.6 ± 12.5               48.0 ± 14.5               59.5 ± 24.4

  Lipase, IU/L         7-60           48.8 ± 33.4      52.9 ± 38.2     17.7 ± 7.2                30.7 ± 5.0                35.3 ± 22.7

  Ammonia, µg/dL       15-45          141.3 ± 113.4    52.0 ± 30.3     45.4 ± 10.6               50.5 ± 10.9               36.2 ± 12.1

  Cholesterol, mg/dL   90-250         99.3 ± 37.2      127.0 ± 31.4    140.4 ± 48.9              167.5 ± 17.7              189.7 ± 35.7

  Glucose, mg/dL       60-108         135.3 ± 81.7     131.3 ± 47.0    120.6 ± 9.5               109.2 ± 23.0              107.9 ± 25.4

  BUN, mg/dL           8-20           23.0 ± 24.3      19.8 ± 7.3      20.1 ± 6.5                19.3 ± 3.2                17.2 ± 4.1

  Cr, mg/dL            0.6-1.3        1.4 ± 1.1        1.1 ± 0.5       1.2 ± 0.4                 1.2 ± 0.4                 1.1 ± 0.3

  Mg, mg/dL            1.5-2.5        0.8 ± 0.3        1.6 ± 0.3       1.6 ± 0.2                 1.5 ± 0.2                 1.5 ± 0.7

  Na, mmol/L           135-145        135.7 ± 6.1      137.7 ± 4.3     139.7 ± 3.4               140.1 ± 2.4               140.1 ± 3.3

  K, mmol/L            3.5-5.5        3.8 ± 0.6        4.4 ± 0.7       4.5 ± 0.5                 4.4 ± 0.6                 4.5 ± 0.4

  Cl, mmol/L           98-110         103.1 ± 6.1      103.7 ± 5.3     105.7 ± 4.1               104.4 ± 4.2               104.1 ± 3.9
  ---------------------------------------------------------------------------------------------------------------------------------------------------

Hgb: hemoglobin, Hct: hematocrit, WBC: white blood cell, Lym: lymphocyte, CRP: c-reactive protein, Alb: albumin, GOT: glutamic-oxaloacetic transaminase, GPT: glutamic-pyruvate transaminase, T.B: total bilirubin, D.B: direct bilirubin, ALP: alkaline phosphatase, LDH: lactate dehydrogenase, BUN: blood urea nitrogen, Cr: creatinine, Mg: magnesium, Na: sodium, K: potassuum, Cl: chloride.

^\*^Data expressed as mean ± standard deviation.

###### Change of nutrient intake of patients

![](cnr-4-242-i003)

  -----------------------------------------------------------------------------------------------------------------------------------------------
                    KDRIs   Preoperative\        Discharge\        Postoperative 3 months\   Postoperative 6 months\   Postoperative 12 months\
                            (n = 33)             (n = 33)          (n = 32)                  (n = 31)                  (n = 28)
  ----------------- ------- -------------------- ----------------- ------------------------- ------------------------- --------------------------
  Energy, kcal      2400    1518.3 ± 556.9^\*^   1692.6 ± 468.8    1762.8 ± 675.2            1902.3 ± 550.5            2013.5 ± 690.1

  Protein, g        55      54.1 ± 16.9          58.2 ± 22.7       61.3 ± 12.2               68.3 ± 16.5               71.2 ± 21.7

  Fat, g            \-      34.3 ± 14.5          36.9 ± 10.9       33.7 ± 11.0               39.3 ± 7.1                42.4 ± 9.1

  Carbohydrate, g   \-      191.9 ± 53.6         206.0 ± 43.5      238.0 ± 34.8              246.5 ± 25.6              251.4 ± 104.2

  Fiber, g          25      10.6± 5.6            11.5 ± 2.7        16.5 ± 3.5                15.4 ± 2.9                13.6 ± 3.6

  Calcium, mg       750     405.3 ± 202.0        471.8 ± 285.1     579.2 ± 383.4             481.2 ± 314.9             464.3 ± 203.8

  Phosphorous, mg   700     1036.0 ± 370.2       909.9 ± 375.2     1115.0 ± 523.2            1916.3 ± 429.9            1780.6 ± 525.4

  Iron, mg          10      9.6 ± 4.8            10.0 ± 6.5        13.3 ± 2.6                11.7 ± 5.8                11.2 ± 4.5

  Sodium, mg        1500    3877.5 ± 1308.8      4049.9 ± 1949.5   3991.4 ± 2736.0           4528.5 ± 2241.7           4025.9 ± 2746.1

  Potassium, mg     3500    2090.5 ± 689.2       2164.8 ± 979.6    2625.9 ± 1314.0           2155.1 ± 1086.0           2551.7 ± 1344.2

  Zinc, mg          9       6.6 ± 3.4            7.1 ± 2.1         8.9 ± 3.3                 9.3 ± 2.6                 9.1 ± 1.2

  Vitamin A, µgRE   750     644.5 ± 264.5        700.4 ± 180.8     740.4 ± 220.7             782.7 ± 394.1             878.6 ± 287.2

  Vitamin B1, mg    1.2     1.2 ± 0.6            1.2 ± 0.4         1.3 ± 0.6                 1.4 ± 0.5                 1.5 ± 0.67

  Vitamin B2, mg    1.5     1.3 ± 0.6            1.5 ± 0.4         1.3 ± 0.5                 1.8 ± 0.4                 1.3 ± 0.6

  Vitamin B6, mg    1.5     1.9 ± 0.8            1.7 ± 0.8         1.7 ± 0.3                 1.9 ± 0.6                 2.0 ± 0.8

  Niacin, mgNE      16      15.7 ± 7.9           14.2 ± 5.5        18.8 ± 7.2                20.0 ± 6.0                17.3 ± 7.1

  Vitamin C, mg     100     61.8 ± 23.4          60.5 ± 20.2       84.0 ± 26.4               88.9 ± 35.3               97.3 ± 16.5

  Folate, µg        400     188.1 ± 80.0         169.5 ± 88.2      176.0 ± 96.9              192.0 ± 65.9              203.0 ± 80.3

  Vitamin E, mg     12      11.6 ± 7.5           11.0 ± 7.1        13.4 ± 8.6                13.4 ± 5.1                14.5 ± 4.7
  -----------------------------------------------------------------------------------------------------------------------------------------------

KDRIs: dietary reference intakes for Koreans.

^\*^Data expressed as mean ± standard deviation.

###### Prevalence of malnutrition according to the nutritional screening tools

![](cnr-4-242-i004)

  -------------------------------------------------------------------------------------------------------------------------------------
                            Preoperative\   Discharge\   Postoperative 3 months\   Postoperative 6 months\   Postoperative 12 months\
                            (n = 33)        (n = 33)     (n = 32)                  (n = 31)                  (n = 28)
  --------- --------------- --------------- ------------ ------------------------- ------------------------- --------------------------
  NRS2002   No-ris          6 (18.2)^\*^    13 (39.3)    18 (56.3)                 23 (74.2)                 26 (92.9)

            At risk         27 (81.8)       20 (60.6)    14 (43.7)                 8 (24.2)                  2 (6.1)

  MUST      Low risk        4 (12.1)        8 (24.2)     15 (46.9)                 22 (71.0)                 25 (89.3)

            Moderate risk   10 (30.3)       14 (42.4)    12 (37.5)                 7 (22.5)                  3 ( 10.7)

            High risk       19 (57.6)       11 (33.4)    5 (15.6)                  2 (6.5)                   0 (0.0)

  SGA       Adequate        5 (15.2)        11 (33.4)    17 (53.1)                 23 (74.2)                 25 (89.3)

            Moderate risk   13 (39.4)       15 (45.4)    12 (37.5)                 6 (19.3)                  3 (10.7)

            Severe risk     15 (45.4)       7 (21.2)     3 (9.4)                   2 (6.5)                   0 (0.0)
  -------------------------------------------------------------------------------------------------------------------------------------

NRS 2002: nutritional risk screening 2002, MUST: malnutrition universal screening tool, SGA: subjective global assessment.

^\*^Data expressed as number (%).

###### Diagnostic value for the nutritional screening tools relative to subjects\' mortality at 12 months after liver transplantation

![](cnr-4-242-i005)

                   Sensitivity              Specificity        Accuracy           PPV                NPV
  ---------------- ------------------------ ------------------ ------------------ ------------------ ------------------
  Preop. NRS2002   87.1 (75.9-99.0)^\*,†^   74.4 (71.3-91.6)   83.3 (68.0-92.8)   80.5 (71.1-95.6)   71.2 (78.1-85.0)
  Preop. MUST      82.0 (70.4-88.5)         61.4 (66.1-90.0)   78.8 (60.7-89.1)   82.6 (66.1-99.8)   76.0 (68.4-90.5)
  Preop. SGA       92.0 (82.4-100.0)        79.5 (70.9-96.7)   91.9 (70.8-98.9)   88.0 (78.7-94.7)   79.0 (72.7-93.0)

^\*^95% confidence intervals were calculated using Wilson\'s method.

NRS 2002: nutritional risk screening 2002, MUST: malnutrition universal screening tool, SGA: subjective global assessment, PPV: positive predictive value, NPV: negative predictive value.

^†^Data expressed as percentage.
